Rationale for pertussis booster vaccination throughout life in Europe

F Zepp, U Heininger, J Mertsola… - The Lancet infectious …, 2011 - thelancet.com
Although the introduction of universal pertussis immunisation in infants has greatly reduced
the number of reported cases in infants and young children, disease incidence has been …

Immune persistence after pertussis vaccination

Z Chen, Q He - Human vaccines & immunotherapeutics, 2017 - Taylor & Francis
Pertussis is one of the most prevalent vaccine-preventable diseases worldwide. The true
infection rate is significantly higher than the reported incidence rate. An increased …

A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent …

SA Halperin, JM Langley, L Ye… - Clinical Infectious …, 2018 - academic.oup.com
Background Immunization of pregnant women with tetanus-diphtheria-acellular pertussis
vaccine (Tdap) provides protection against pertussis to the newborn infant. Methods In a …

Pertussis in early infancy: disease burden and preventive strategies

P McIntyre, N Wood - Current opinion in infectious diseases, 2009 - journals.lww.com
Adult booster immunization, either universal or targeted (mothers during pregnancy or
'cocoon'), would probably be effective but is challenging to implement. If shown to be safe …

Dynamics of the humoral immune response to a prime-boost Ebola vaccine: quantification and sources of variation

C Pasin, I Balelli, T Van Effelterre, V Bockstal… - Journal of …, 2019 - Am Soc Microbiol
The Ebola vaccine based on Ad26. ZEBOV/MVA-BN-Filo prime-boost regimens is being
evaluated in multiple clinical trials. The long-term immune response to the vaccine is …

Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine

T Dalby, JW Petersen, ZB Harboe… - Journal of medical …, 2010 - microbiologyresearch.org
The measurement of IgG anti-pertussis toxin (IgG anti-PT) antibodies by ELISA is a
frequently used method for studying the antibody responses after pertussis vaccination and …

[HTML][HTML] Immunization against pertussis in adolescents and adults

S Esposito, N Principi - Clinical Microbiology and Infection, 2016 - Elsevier
Pertussis is a highly contagious infectious disease caused by Bordetella pertussis that can
be extremely serious, particularly in young infants. For many years the efforts of health …

[PDF][PDF] The immunological basis for immunization series: module 23: influenza vaccines

World Health Organization - 2017 - apps.who.int
This module is part of the WHO series The Immunological Basis for Immunization, which was
initially developed in 1993 as a set of eight modules, comprising one module on general …

[HTML][HTML] Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular …

V Pool, A Tomovici, DR Johnson, DP Greenberg… - Vaccine, 2018 - Elsevier
Background In a prospective, randomized pivotal phase III clinical trial, the immunogenicity
and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus …

Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose

SA Halperin, D Scheifele, G De Serres, F Noya… - Vaccine, 2012 - Elsevier
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine during …